Terman Stanley A, Steinberg Karl E, Hinerman Nathaniel
Caring Advocates Sausalito California USA.
Shiley Haynes Institute for Palliative Care California State University, San Marcos San Marcos California USA.
Alzheimers Dement (Amst). 2024 Mar 15;16(1):e12527. doi: 10.1002/dad2.12527. eCollection 2024 Jan-Mar.
Patients living with advanced dementia (PLADs) face several challenges to attain the goal of avoiding prolonged dying with severe suffering. One is how to determine when PLADs' current suffering becomes severe enough to cease all life-sustaining treatments, including withdrawing assistance with oral feeding and hydrating, a controversial order. This article broadens the concept of suffering by including suffering that cannot be observed contemporaneously and the suffering of loved ones. Four paradigm shifts operationalize these concepts. During advance care planning, patients can judge which future clinical conditions would cause severe suffering. To decide when to allow patients to die, treating physicians/providers only need to assess if patients have reached patients' previously judged, qualifying conditions. Questions: Will this protocol prevent PLADs' prolonged dying with suffering? Deter early-stage dementia patients from committing preemptive suicide? Sway decision-making surrogates from withholding life-sustaining treatments from patients with middle-stage dementia? Provoke providers' resistance to relinquish their traditional, unilateral authority to determine patients' suffering?
晚期痴呆症患者(PLADs)在实现避免在极度痛苦中延长死亡时间这一目标上面临诸多挑战。其中之一是如何确定PLADs当前的痛苦何时严重到足以停止所有维持生命的治疗,包括停止提供经口喂食和补液的帮助,这是一个有争议的指令。本文通过纳入无法同时观察到的痛苦以及亲人的痛苦,拓宽了痛苦的概念。四个范式转变将这些概念付诸实践。在预先护理计划期间,患者可以判断哪些未来的临床状况会导致严重痛苦。为了决定何时允许患者死亡,主治医生/医疗服务提供者只需评估患者是否已达到患者先前判断的符合条件的状况。问题:该方案能否防止PLADs在痛苦中延长死亡时间?能否阻止早期痴呆症患者进行先发制人的自杀?能否改变决策代理人对中期痴呆症患者不进行维持生命治疗的决定?能否引发医疗服务提供者抵制放弃其传统的单方面确定患者痛苦的权力?